» Articles » PMID: 12720526

Medical Comorbidity in Schizophrenia

Overview
Journal Med J Aust
Specialty General Medicine
Date 2003 May 2
PMID 12720526
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia has been described as a "life-shortening disease", and physical comorbidity accounts for 60% of premature deaths not related to suicide. People with schizophrenia and other mental illnesses have a higher rate of preventable risk factors such as smoking, high alcohol consumption, poor diet, and lack of exercise. Recognition and management of morbidity in people with mental illness are made more difficult by barriers related to the patient, the illness, the attitudes of medical practitioners, and the structure of healthcare delivery services. Improved detection and treatment of medical illness in people with schizophrenia will have significant benefits for their psychosocial functioning and overall quality of life.

Citing Articles

Oral health knowledge, attitudes, and practices of people living with mental illness: a mixed-methods systematic review.

Johnson A, Kenny A, Ramjan L, Raeburn T, George A BMC Public Health. 2024; 24(1):2263.

PMID: 39164704 PMC: 11337876. DOI: 10.1186/s12889-024-19713-1.


The burden of schizophrenia in the Middle East and North Africa region, 1990-2019.

Safiri S, Noori M, Nejadghaderi S, Shamekh A, Sullman M, Collins G Sci Rep. 2024; 14(1):9720.

PMID: 38678101 PMC: 11055947. DOI: 10.1038/s41598-024-59905-8.


A streamlined multidisciplinary metabolic clinic in psychiatric recovery service: a pilot study.

Leung K, Bakr B, Chung C, Parmar M, Elhindi J, Brakoulias V Front Psychiatry. 2024; 15:1344453.

PMID: 38445084 PMC: 10913053. DOI: 10.3389/fpsyt.2024.1344453.


Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis.

Zinellu A, Sedda S, Mangoni A Antioxidants (Basel). 2023; 12(8).

PMID: 37627479 PMC: 10451270. DOI: 10.3390/antiox12081484.


Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia.

Oh J, Oh J, Kim D, Youn H, Kim S, Kim S Clin Psychopharmacol Neurosci. 2023; 21(1):126-134.

PMID: 36700319 PMC: 9889906. DOI: 10.9758/cpn.2023.21.1.126.